drugset / Trial / NCT00942617
Measurement of Platelet Dense Granule Release in Healthy Volunteers
Withdrawn
Vanderbilt University
NaSingle-groupOpen-labelBasic science
Summary
Aspirin has been shown to reduce cardiovascular events in at risk individuals. Elucidation of mechanisms of aspirin resistance and a possible loss of effect of aspirin over time with chronic aspirin treatment necessitate a more precise method of measuring the "release phase" of platelet activation, including the release of dense granules from platelets.
Timeline
- Start
- 2009-07
- Primary completion
- 2012-06
- Completion
- 2012-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 40 mg | — |